FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LETERMOVIR
异名/同义词(4S)-2-(8-FLUORO-2-(4-(3-METHOXYPHENYL)PIPERAZIN-1-YL)-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-3,4-DIHYDROQUINAZOLIN-4-YL)ACETIC ACID
2-((4S)-8-FLUORO-2-(4-(3-METHOXYPHENYL)PIPERAZIN-1-YL)-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-4H-QUINAZOLIN-4-YL)ACETIC ACID
4-QUINAZOLINEACETIC ACID, 8-FLUORO-3,4-DIHYDRO-2-(4-(3-METHOXYPHENYL)-1-PIPERAZINYL)-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-, (4S)-
AIC246
AIC-246
LETERMOVIR
LETERMOVIR [INN]
LETERMOVIR [JAN]
LETERMOVIR [MI]
LETERMOVIR [ORANGE BOOK]
LETERMOVIR [USAN]
LETERMOVIR [WHO-DD]
MK-8228
PREVYMIS
CAS登记号917389-32-3
物质唯一标识(Unique Ingredient Identifier)1H09Y5WO1F
分子式C29H28F4N4O4
国际化合物标识(International Chemical Identifier,InChI)FWYSMLBETOMXAG-QHCPKHFHSA-N
SMILESc1(C(F)(F)F)cc(N2C(=Nc3c(cccc3F)[C@@H]2CC(=O)O)N4CCN(c5cccc(c5)OC)CC4)c(OC)cc1
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System